357 related articles for article (PubMed ID: 23730837)
21. Effects of traditional Chinese medicine formula Le-Cao-Shi on hepatitis B: In vivo and in vitro studies.
Zhao Q; Ren X; Chen M; Yue SJ; Zhang MQ; Chen KX; Guo YW; Shao CL; Wang CY
J Ethnopharmacol; 2019 Nov; 244():112132. PubMed ID: 31381954
[TBL] [Abstract][Full Text] [Related]
22. [Inhibiting effects of root of Mallotus apelta on duck hepatitis B virus].
Xu S; Lü ZP; Cai HB; Zhang XG; Liu Q; Tan Y
Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):285-8. PubMed ID: 16696917
[TBL] [Abstract][Full Text] [Related]
23. Anti-hepatitis B virus activities of triterpenoid saponin compound from Potentilla anserine L.
Zhao YL; Cai GM; Hong X; Shan LM; Xiao XH
Phytomedicine; 2008 Apr; 15(4):253-8. PubMed ID: 18337074
[TBL] [Abstract][Full Text] [Related]
24. [Inhibitory effect of trisodium phosphonoformate (PFA) on duck hepatitis B virus (DHBV) DNA in vivo].
Chen X; Chen H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):277-81. PubMed ID: 15617348
[TBL] [Abstract][Full Text] [Related]
25. Taraxacum mongolicum extract exhibits a protective effect on hepatocytes and an antiviral effect against hepatitis B virus in animal and human cells.
Jia YY; Guan RF; Wu YH; Yu XP; Lin WY; Zhang YY; Liu T; Zhao J; Shi SY; Zhao Y
Mol Med Rep; 2014 Apr; 9(4):1381-7. PubMed ID: 24481875
[TBL] [Abstract][Full Text] [Related]
26. Duck hepatitis B virus model for screening of antiviral agents from medicinal herbs.
Mi Z; Chen H; Zhang X; Shao X; Li Z; Wu X
Chin Med J (Engl); 1995 Sep; 108(9):660-4. PubMed ID: 8575230
[TBL] [Abstract][Full Text] [Related]
27. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis.
Reaiche GY; Le Mire MF; Mason WS; Jilbert AR
Virology; 2010 Oct; 406(2):286-92. PubMed ID: 20705309
[TBL] [Abstract][Full Text] [Related]
28. [Uses of duck hepatitis B virus polymerase and reverse transcriptase in the evaluation of anti-hepatitis B virus drugs].
Guo JT; Chen HS; Tang XS
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Aug; 12(8):480-2, 454. PubMed ID: 1282399
[TBL] [Abstract][Full Text] [Related]
29. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
[TBL] [Abstract][Full Text] [Related]
30. Antiviral effects of PNA in duck hepatitis B virus infection model.
Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
[TBL] [Abstract][Full Text] [Related]
31. Perspectives for the treatment of hepatitis B virus infections.
De Clercq E
Int J Antimicrob Agents; 1999 Jul; 12(2):81-95. PubMed ID: 10418752
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo anti-hepatitis B virus activities of the lignan nirtetralin B isolated from Phyllanthus niruri L.
Liu S; Wei W; Li Y; Lin X; Shi K; Cao X; Zhou M
J Ethnopharmacol; 2014 Nov; 157():62-8. PubMed ID: 25260580
[TBL] [Abstract][Full Text] [Related]
33. [The inhibitory effect of compound liuyuexue on DHBV DNA].
Zhang SJ; Lin J; Jiang WZ; Huang CX; Huamg RB
Zhong Yao Cai; 2007 Feb; 30(2):191-3. PubMed ID: 17571772
[TBL] [Abstract][Full Text] [Related]
34. Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.
Foster WK; Miller DS; Scougall CA; Kotlarski I; Colonno RJ; Jilbert AR
J Virol; 2005 May; 79(9):5819-32. PubMed ID: 15827196
[TBL] [Abstract][Full Text] [Related]
35. Clinical and experimental effectiveness of Astragali compound in the treatment of chronic viral hepatitis B.
Tang LL; Sheng JF; Xu CH; Liu KZ
J Int Med Res; 2009; 37(3):662-7. PubMed ID: 19589248
[TBL] [Abstract][Full Text] [Related]
36. [Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling].
Hu Q; Fang Y; Zhang ZM; Zhang XY; Zhang ZH; Yang DL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):113-5. PubMed ID: 18574531
[TBL] [Abstract][Full Text] [Related]
37. Antiviral activity of methyl helicterate isolated from Helicteres angustifolia (Sterculiaceae) against hepatitis B virus.
Huang Q; Huang R; Wei L; Chen Y; Lv S; Liang C; Zhang X; Yin F; Li H; Zhuo L; Lin X
Antiviral Res; 2013 Nov; 100(2):373-81. PubMed ID: 24055834
[TBL] [Abstract][Full Text] [Related]
38. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
[TBL] [Abstract][Full Text] [Related]
39. [Inhibition of extracts of ampelopsis sinica roots on DHBVsAg in sera of ducklings].
Chen K; Li H; Chen Y; Zhang C
Zhong Yao Cai; 2000 Jan; 23(1):41-2. PubMed ID: 12575118
[TBL] [Abstract][Full Text] [Related]
40. Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies.
Zoulim F; Berthillon P; Guerhier FL; Seigneres B; Germon S; Pichoud C; Cheng YC; Trepo C
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S460-3. PubMed ID: 12534778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
